Details of the Drug

General Information of Drug (ID: DMI3YLK)

Drug Name
LA-EP2006
Indication
Disease Entry ICD 11 Status REF
Neutropenia 4B00.0 Phase 3 [1]
Cross-matching ID
TTD ID
D07JZT

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Granulocyte colony-stimulating factor (CSF3) TT5TQ2W CSF3_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Neutropenia
ICD Disease Classification 4B00.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Granulocyte colony-stimulating factor (CSF3) DTT CSF3 7.72E-01 -1.68E-03 -0.01
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01516736) Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 724518).